FDA OKs new agent to block chemotherapy-induced neutropeniaNovember 29, 2023Mixed TopicsMultiple MyelomaBreast Cancer
FDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023Mixed TopicsAMLMultiple Myeloma
ClonoSEQ Testing for Minimal Residual Disease in Multiple Myeloma: Cleveland VA Experience And Cost AnalysisSeptember 10, 2023Multiple MyelomaOncology
Comparing Outcomes and Toxicities With Standard and Reduced Dose Melphalan in Autologous Stem Cell Transplant Patients With Multiple MyelomaSeptember 10, 2023Multiple MyelomaOncology
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaAML
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
